Skip to main content

Table 3 Receptor binding characteristics to κ 2 receptor sites

From: δ Opioidmimetic Antagonists: Prototypes for Designing a New Generation of Ultraselective Opioid Peptides

Peptide

Kiδ(μM)

Kiδ/Kiκ

Kiμ/Kiκ

1. Dmt-Tic-OH

23,806 ± 2,697 (3)

0.0000009

0.14

2. Dmt-Tic-NH2

1,943 ± 113 (3)

0.0006

0.14

3. Dmt-d-Tic-OH

9,863 ± 2,621 (3)

0.0014

0.02

4. Dmt-d-Tic-NH2

5,291 ± 105 (3)

0.011

0.0007

5. Dmt-Tic-CH2OH

1,107 ± 158 (4)

0.0004

0.14

6. Tyr-Tic-OH

>60,000

11. Dmt-Tic-Ala-OH

>50,000 (3)

<0.000006

0.12

12. Dmt-Tic-Ala-NH2

8,694 ± 1,254 (5)

0.000028

0.005

13. Dmt-d-Tic-Ala-OH

9,752 ± 2,418 (3)

0.009

0.008

14. Dmt-d-Tic-Ala-NH2

7,087 ± 2,181 (3)

0.0007

0.0008

15. Tyr-Tic-Ala-OH

>60,000

16. Tyr-Tic-Ala-NH2

>60,000

  1. Ki, affinity constant. Dynorphin A-(1-13)-OH (porcine) is included as an internal control. The κ selectivities relative to δ (KiδKiκ) and μ receptors (Kiμ/Kiκ) are from the binding data in Table 2. SEM is listed only for n = 3–5 as indicated by the number in the parenthesis.